Dr West provides a realistic look at the benefits and risks of immunotherapy in lung cancer and explains how these medications work. View more at http://curetoday.com/ CURE: Combining science and humanity to make cancer understandable. Curetoday: Published on Oct 25, 2017.
What is ...
Immunotherapy?
... air pollutants in Allegheny County have been shown to correlate with a higher risk of lung cancer.
CANCER RESEARCH INSTITUTE
Clinical Trials for Lung Cancer
Once thought of as a type of cancer that was poorly recognized by the immune system, lung cancer has recently emerged as an exciting new target of immune-based therapies [1]. Some patients with advanced lung cancer have benefited greatly from immunotherapies, experiencing durable remissions and prolonged survival. Current immunotherapies for lung cancer can be broken into four main categories: checkpoint inhibitors, monoclonal antibodies, therapeutic vaccines, and adoptive cell therapy.